| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |